(1)
Early Phase I Results for 4-Demethyl-4-Cholesteryloxypenclo-Medine [DM-CHOC-PEN] As Therapy in Adolescent and Young Adult (AYA) Subjects With Advanced Malignancies . J. Can. Res. Updates 2018, 7 (3), 75-78. https://doi.org/10.6000/1929-2279.2018.07.03.2.